卵巢癌患者的发病率和死亡率的长期趋势分析:基于SEER数据库的大型样本研究
Hongwei Zhao1, Yu Zhang1, Qianyong Zhu1
1Department of Obstetrics and Gynecology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan University People's Hospital, No. 7 Weiwu Road, Jinshui District, Zhengzhou, Henan 450003, P.R. China.
Postgraduate medical journal
|October 30, 2024
概括
在美国,2000年至2017年期间,卵巢癌发病率和死亡率显著下降. 趋势因阶段,组织学和等级而异,影响生存结果.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 癌症研究 癌症研究
背景情况:
- 卵巢癌在全球具有很高的发病率和死亡率.
- 卵巢癌发病率和死亡率的长期趋势需要持续调查.
研究的目的:
- 分析美国卵巢癌的长期发病率和死亡率趋势.
- 确定影响卵巢癌患者生存的因素.
主要方法:
- 使用了监测,流行病学和最终结果 (SEER) 数据库 (2000-2017年).
- 用人joinpoint回归分析用于趋势评估 (年平均百分比变化 - AAPC).
- 使用卡普兰-梅尔曲线和考克斯回归进行了生存分析.
主要成果:
- 发生率显示显著下降 (AAPC:-1.9%).
- 总体和癌症特异性死亡率显著下降 (AAPC分别为-5.0%和-4.6%).
- 在远期,血清/布伦纳亚型和II/III等级中观察到下降趋势;生存受年龄,种族,组织学,等级,收入和治疗的影响.
结论:
- 卵巢癌的发病率和死亡率在2000年至2017年间呈现出统计学上显著的下降.
- 不同患者亚组的趋势各不相同,突出显示了个性化治疗策略的必要性.
- 调查结果为公共卫生政策和临床实践提供了关于卵巢癌管理的关键数据.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Actuarial Approach
63
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63
Comparing the Survival Analysis of Two or More Groups
155
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
155
Kaplan-Meier Approach
102
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
102
Introduction To Survival Analysis
184
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
184


